Skip to NavigationSkip to content

News

Researchers from the University of Bristol and NHS Blood and Transplant have managed to perfect a technique whereby it is possible to manufacture red...
Following on from the positive opinion given to Xeljanz in January of this year, Pfizer’s drug has now been given European Commission marketing...
Infectex, a Russian portfolio company of Maxwell Biotech Venture Fund, announced that it had found positive results from its latest Phase 2b-3...
AstraZeneca has been boosted by the news that its drug, Tagrisso, has become its first drug to be approved under China’s new Priority Review pathway.
Merck KGaA and Pfizer have won approval for the fourth immunotherapy treatment to enter the market, with an indication in metastatic Merkel cell...
Eli Lilly’s latest press release indicated that it would be spending $850 million in developing its worldwide US operations, particularly in its...
As Novartis' once-promising heart failure drug plummets in Phase 3 trials and the FDA approves the first Parkinson's treatment in a decade, check out...
Cancer Research UK has revealed a £10 million investment into PRECISION-Panc, a pancreatic cancer-focused project which aims to improve patient...
This report provides an analysis of the Australian pharmaceutical and biopharmaceutical industry through the lens of patents. By using the scale and...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches